Últimos Artículos de Lancet Diabetes & Endocrinology
- [Editorial] Diabetes-related complications: an evolving spectrum
- [Articles] Natural history of thyroid function in ageing: an individual participant data analysis of 137 488 participants from 31 prospective cohort studies
- [Comment] What is an optimal serum thyroid-stimulating hormone value in older adults?
- [Comment] Burosumab treatment for children younger than 12 months with X-linked hypophosphataemia
- [Series] Strengthening diabetes care in sub-Saharan Africa: health systems, digital innovations, lifestyle interventions, and socioeconomic dimensions
- [Series] Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies
- [Series] Burden and determinants of diabetes in sub-Saharan Africa
- [Articles] Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study
- [Comment] Diabetes in sub-Saharan Africa: aligning biology, culture, and health systems for improved outcomes
- [Articles] Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
- [Comment] Freedom through technology: transforming management of type 2 diabetes
- [Comment] A conceptual framework for modernising and right-sizing global diabetes care
- [Articles] Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
- [Comment] What REDEFINE 5 signals for obesity trials in Asia and beyond
- [Correspondence] Implications of microplastics as emerging endocrine disruptors
- [Comment] Low visceral fat and kidney disease risk in men with diabetes
- [Articles] Sex-specific and BMI-specific associations between visceral fat and diabetic kidney disease in patients with diabetes: a large-scale multicentre prospective cohort study
- [Review] Secondary causes of diabetes: a crossroad of endocrinology and oncology
- [Editorial] World Autism Awareness Day: autism and metabolic health
- [Corrections] Correction to Lancet Diabetes Endocrinol 2025; 13: 935–48